accchhhhhhhhhhhh,,,,,,,,,,,,,,,,

1) We are at the very least 1 year + laaaaterrrrr into this BoM trial than originally scheduled.

2) We are $XX million over the original budget for this BoM trial.

3) We are not even close to starting the VCD trial nor the CKD trial, which possibly the CKD trial has had the most impressive initial data returned so far.

4) The HIV/208 notice given out by Management has not had any follow up based on the assumption since we have had no updates and thus most likely no interest outside.

5) RVX has a forward plan but it is heavily time based and not for the impatient. Will we be sold? Flip a coin!

6) The share price prize for all is a NASDAQ listing. Piece meal PPs until then. Turd eye will pillage what they can right up to loan maturity.

7) Commercial prize will be being chosen as standard of care in health care systems and by insurance underwriters.

8) All just my opinion. Fingers and all appendages crossed for sucess in BoM.